Cephalosporin Antibacterial [EPC]

Cephalosporin Antibacterial [EPC] was reported 8581 times

Drugs of the Cephalosporin Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MOUTH BREATHING 18 0.0414
1 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 41 0.0386
2 PORTAL VENOUS GAS 11 0.0303
3 HYPERPARATHYROIDISM SECONDARY 65 0.0259
4 SYRINGOMYELIA 7 0.0252
5 REBOUND ACID HYPERSECRETION 76 0.0251
6 DIARRHOEA INFECTIOUS 19 0.0241
7 NEPHROGENIC ANAEMIA 108 0.0233
8 DERMATITIS DIAPER 13 0.0184
9 PNEUMONIA MYCOPLASMAL 13 0.0163
10 OTITIS MEDIA ACUTE 12 0.0163
11 VANISHING BILE DUCT SYNDROME 18 0.0161
12 ALLERGY TO ARTHROPOD BITE 5 0.0156
13 HEAT EXHAUSTION 12 0.0149
14 SERUM SICKNESS-LIKE REACTION 6 0.0095
15 END STAGE RENAL DISEASE 169 0.0093
16 UPPER RESPIRATORY TRACT INFLAMMATION 10 0.0083
17 INFUSION SITE MASS 9 0.0083
18 MASTOIDITIS 8 0.0082
19 INFUSION SITE DISCHARGE 14 0.0080
20 CHRONIC KIDNEY DISEASE 572 0.0075
21 INFUSION SITE NODULE 7 0.0073
22 RHINITIS ALLERGIC 31 0.0070
23 INFUSION SITE BRUISING 15 0.0069
24 TYMPANIC MEMBRANE PERFORATION 11 0.0065
25 ADENOCARCINOMA GASTRIC 6 0.0065
26 INFUSION SITE HAEMORRHAGE 20 0.0061
27 ESSENTIAL HYPERTENSION 11 0.0060
28 SNORING 22 0.0058
29 INFUSION SITE DISCOMFORT 6 0.0058
30 RECALLED PRODUCT ADMINISTERED 53 0.0056
31 EAR INFECTION 147 0.0055
32 SHOULDER FRACTURE 9 0.0055
33 OBSTRUCTIVE SLEEP APNOEA SYNDROME 8 0.0055
34 PNEUMONIA STREPTOCOCCAL 6 0.0055
35 DRY AGE-RELATED MACULAR DEGENERATION 6 0.0054
36 MULTIPLE ALLERGIES 42 0.0054
37 GASTROINTESTINAL BACTERIAL INFECTION 6 0.0052
38 ANTIBIOTIC THERAPY 5 0.0051
39 SERUM SICKNESS 14 0.0050
40 CHOLESTATIC LIVER INJURY 11 0.0049
41 ECONOMIC PROBLEM 73 0.0048
42 CLOSTRIDIUM DIFFICILE COLITIS 49 0.0046
43 INFUSION SITE SWELLING 29 0.0046
44 LYMPHADENITIS 11 0.0045
45 MIDDLE EAR EFFUSION 10 0.0045
46 INFUSION SITE PRURITUS 14 0.0044
47 INTERMITTENT CLAUDICATION 7 0.0044
48 RHONCHI 6 0.0043
49 BODY TEMPERATURE ABNORMAL 8 0.0043
50 INFUSION SITE ERYTHEMA 36 0.0043
51 OTITIS MEDIA 14 0.0042
52 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 23 0.0042
53 BILIARY DYSKINESIA 7 0.0041
54 MILIARIA 7 0.0041
55 STREPTOCOCCAL INFECTION 22 0.0039
56 TUBULOINTERSTITIAL NEPHRITIS 74 0.0039
57 PNEUMONIA PSEUDOMONAL 6 0.0039
58 HEPATOSPLENOMEGALY 10 0.0039
59 SINUSITIS 399 0.0039
60 MICROCYTIC ANAEMIA 8 0.0038
61 CLOSTRIDIAL INFECTION 13 0.0038
62 RENAL INJURY 114 0.0038
63 URINARY BLADDER HAEMORRHAGE 8 0.0038
64 SPUTUM DISCOLOURED 36 0.0038
65 RENAL TUBULAR NECROSIS 37 0.0038
66 PHARYNGITIS STREPTOCOCCAL 40 0.0037
67 SEASONAL ALLERGY 52 0.0037
68 THROMBOPHLEBITIS SUPERFICIAL 11 0.0036
69 CLOSTRIDIUM TEST POSITIVE 8 0.0036
70 TONSILLECTOMY 6 0.0036
71 BLOOD CHLORIDE INCREASED 6 0.0035
72 SINUS PAIN 8 0.0034
73 INFUSION SITE PAIN 44 0.0034
74 SINUS OPERATION 8 0.0034
75 OXYGEN CONSUMPTION INCREASED 8 0.0033
76 FAECES DISCOLOURED 70 0.0032
77 CHRONIC SINUSITIS 12 0.0032
78 PROTEIN TOTAL DECREASED 12 0.0032
79 MECHANICAL VENTILATION 6 0.0032
80 PANCREATIC CYST 6 0.0031
81 RENAL FAILURE 417 0.0031
82 UPPER RESPIRATORY TRACT INFECTION 145 0.0031
83 ANHEDONIA 82 0.0031
84 NASAL SEPTUM DEVIATION 6 0.0031
85 ABSCESS LIMB 13 0.0030
86 RESPIRATORY TRACT INFECTION 78 0.0030
87 CHOLECYSTITIS CHRONIC 20 0.0030
88 CLOSTRIDIUM DIFFICILE INFECTION 65 0.0030
89 SKIN ABRASION 14 0.0030
90 VIRAL UPPER RESPIRATORY TRACT INFECTION 14 0.0029
91 PARANASAL SINUS DISCOMFORT 11 0.0029
92 ACUTE SINUSITIS 5 0.0029
93 INFUSION SITE EXTRAVASATION 18 0.0029
94 HAEMATOLOGICAL INFECTION 7 0.0029
95 PHARYNGEAL ERYTHEMA 6 0.0028
96 SCREAMING 18 0.0028
97 FORCED EXPIRATORY VOLUME DECREASED 8 0.0028
98 HAEMOLYTIC ANAEMIA 25 0.0028
99 RESPIRATORY SYNCYTIAL VIRUS INFECTION 24 0.0028
100 CANCER PAIN 7 0.0027
101 PRE-EXISTING CONDITION IMPROVED 17 0.0027
102 PSEUDOMEMBRANOUS COLITIS 6 0.0027
103 IRON DEFICIENCY 12 0.0027
104 PNEUMONIA BACTERIAL 24 0.0026
105 GASTRIC INFECTION 10 0.0026
106 PANCREATITIS NECROTISING 6 0.0026
107 OVERWEIGHT 14 0.0026
108 NECROTISING FASCIITIS 9 0.0026
109 ACUTE KIDNEY INJURY 384 0.0025
110 PAINFUL RESPIRATION 6 0.0025
111 RHINITIS 20 0.0025
112 NEPHROPATHY 23 0.0025
113 GASTROENTERITIS VIRAL 44 0.0024
114 PHARYNGITIS 30 0.0024
115 CATHETER SITE HAEMORRHAGE 6 0.0024
116 BRONCHITIS 174 0.0023
117 INFUSION SITE REACTION 7 0.0023
118 LEFT VENTRICULAR HYPERTROPHY 10 0.0023
119 CYSTITIS 74 0.0023
120 ACTINIC KERATOSIS 6 0.0023
121 UPPER-AIRWAY COUGH SYNDROME 19 0.0023
122 SINUS DISORDER 45 0.0023
123 CONJUNCTIVAL HYPERAEMIA 8 0.0022
124 OSTEOPENIA 34 0.0022
125 BLOOD CREATININE DECREASED 7 0.0022
126 FUNGAL SKIN INFECTION 9 0.0022
127 EAR CONGESTION 6 0.0022
128 ABDOMINAL HERNIA 10 0.0022
129 DERMATITIS CONTACT 25 0.0022
130 SINUS HEADACHE 13 0.0022
131 ATELECTASIS 21 0.0022
132 EAR PAIN 42 0.0022
133 BENIGN PROSTATIC HYPERPLASIA 11 0.0021
134 AUTOIMMUNE THYROIDITIS 8 0.0021
135 AORTIC VALVE INCOMPETENCE 9 0.0021
136 PANCREATIC CARCINOMA METASTATIC 6 0.0021
137 PARANASAL SINUS HYPERSECRETION 8 0.0021
138 KIDNEY INFECTION 41 0.0021
139 HYPERTONIC BLADDER 6 0.0021
140 RHINOVIRUS INFECTION 8 0.0021
141 PRODUCTIVE COUGH 98 0.0021
142 VIRAL INFECTION 68 0.0020
143 ERYTHEMA MULTIFORME 19 0.0020
144 EYE INFECTION 23 0.0020
145 ARTHROPOD BITE 15 0.0020
146 ATYPICAL PNEUMONIA 6 0.0020
147 BRONCHIOLITIS 7 0.0020
148 URINARY TRACT INFECTION 336 0.0020
149 RESPIRATORY TRACT CONGESTION 31 0.0019
150 DECREASED ACTIVITY 21 0.0019
151 HYPERURICAEMIA 8 0.0019
152 FAILURE TO THRIVE 10 0.0019
153 LIGAMENT SPRAIN 19 0.0019
154 MULTIPLE INJURIES 12 0.0019
155 BLOOD ALBUMIN DECREASED 15 0.0019
156 ENDOMETRIOSIS 9 0.0019
157 PNEUMONIA VIRAL 6 0.0019
158 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
159 ANIMAL BITE 5 0.0019
160 ACUTE RESPIRATORY FAILURE 36 0.0019
161 EAR DISCOMFORT 19 0.0018
162 ABDOMINAL RIGIDITY 5 0.0018
163 THERMAL BURN 13 0.0018
164 TOOTH INFECTION 24 0.0018
165 MUCOUS STOOLS 9 0.0018
166 FOOD ALLERGY 14 0.0018
167 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 14 0.0018
168 LYME DISEASE 6 0.0018
169 STEVENS-JOHNSON SYNDROME 40 0.0018
170 CYTOMEGALOVIRUS VIRAEMIA 8 0.0018
171 ORAL INFECTION 7 0.0018
172 PRODUCT ADMINISTRATION ERROR 36 0.0018
173 SUPRAVENTRICULAR EXTRASYSTOLES 6 0.0018
174 SINUS CONGESTION 24 0.0018
175 INSURANCE ISSUE 27 0.0018
176 CHOLECYSTITIS ACUTE 10 0.0018
177 VASCULAR DEVICE INFECTION 8 0.0018
178 SECRETION DISCHARGE 22 0.0018
179 OBSTRUCTION 7 0.0018
180 PERIPHERAL VASCULAR DISORDER 9 0.0017
181 HOSPICE CARE 17 0.0017
182 PERIPHERAL VENOUS DISEASE 7 0.0017
183 UMBILICAL HERNIA 8 0.0017
184 SPINAL OSTEOARTHRITIS 15 0.0017
185 ACIDOSIS 13 0.0017
186 SKIN INFECTION 19 0.0017
187 IMPAIRED GASTRIC EMPTYING 23 0.0017
188 PNEUMONIA 545 0.0017
189 SUBCUTANEOUS ABSCESS 8 0.0017
190 GINGIVITIS 9 0.0017
191 FULL BLOOD COUNT DECREASED 33 0.0016
192 GALLBLADDER DISORDER 29 0.0016
193 SPLENOMEGALY 19 0.0016
194 FUNGAL INFECTION 54 0.0016
195 PYELONEPHRITIS 14 0.0016
196 PROTEIN URINE PRESENT 8 0.0016
197 SCAR 27 0.0016
198 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
199 GINGIVAL DISORDER 6 0.0016
200 BLOOD URIC ACID INCREASED 9 0.0016
201 CARDIAC FLUTTER 10 0.0015
202 CANDIDA INFECTION 26 0.0015
203 FEELING OF BODY TEMPERATURE CHANGE 9 0.0015
204 TONSILLITIS 8 0.0015
205 FOOT FRACTURE 29 0.0015
206 PNEUMONIA FUNGAL 6 0.0015
207 PSEUDOMONAS INFECTION 13 0.0015
208 PROTHROMBIN TIME PROLONGED 9 0.0015
209 MUSCLE STRAIN 13 0.0015
210 FOOD POISONING 8 0.0015
211 FLANK PAIN 14 0.0015
212 VAGINAL INFECTION 7 0.0015
213 ENURESIS 6 0.0015
214 LUNG INFILTRATION 13 0.0015
215 PERIPHERAL ISCHAEMIA 6 0.0015
216 RIB FRACTURE 30 0.0015
217 SCOLIOSIS 9 0.0015
218 WHEEZING 86 0.0014
219 GASTROINTESTINAL INFECTION 13 0.0014
220 CELLULITIS 73 0.0014
221 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
222 PULMONARY CONGESTION 19 0.0014
223 COVID-19 PNEUMONIA 17 0.0014
224 AORTIC STENOSIS 5 0.0014
225 VITAMIN D DEFICIENCY 14 0.0014
226 WEIGHT FLUCTUATION 15 0.0014
227 SLEEP TERROR 6 0.0014
228 PERIORBITAL SWELLING 8 0.0014
229 OSTEOPOROSIS 58 0.0014
230 CARDIAC FAILURE CHRONIC 6 0.0014
231 DYSPNOEA EXERTIONAL 53 0.0014
232 CHOLECYSTECTOMY 16 0.0014
233 AFFECTIVE DISORDER 11 0.0014
234 FURUNCLE 11 0.0014
235 HORDEOLUM 6 0.0014
236 SNEEZING 31 0.0014
237 TENDON DISORDER 9 0.0014
238 SKIN LACERATION 15 0.0014
239 RALES 8 0.0014
240 DRY THROAT 14 0.0014
241 TONGUE DISCOLOURATION 6 0.0014
242 ONYCHOMYCOSIS 6 0.0014
243 ENDOCARDITIS 7 0.0014
244 APHONIA 19 0.0014
245 CATHETERISATION CARDIAC 6 0.0014
246 PLEURISY 8 0.0013
247 BRONCHIECTASIS 9 0.0013
248 CHOKING 26 0.0013
249 POSTOPERATIVE WOUND INFECTION 9 0.0013
250 INCONTINENCE 14 0.0013
251 GASTROOESOPHAGEAL REFLUX DISEASE 106 0.0013
252 URTICARIA 220 0.0013
253 ILLNESS 135 0.0013
254 SLEEP APNOEA SYNDROME 25 0.0013
255 DRUG ERUPTION 23 0.0013
256 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
257 HIP SURGERY 7 0.0013
258 NASAL CONGESTION 76 0.0013
259 TENDONITIS 20 0.0013
260 DEFAECATION URGENCY 9 0.0013
261 TIBIA FRACTURE 6 0.0013
262 PSYCHOLOGICAL TRAUMA 11 0.0013
263 CARDIAC MURMUR 11 0.0013
264 QUALITY OF LIFE DECREASED 17 0.0013
265 NEPHROLITHIASIS 58 0.0013
266 TRICUSPID VALVE INCOMPETENCE 10 0.0013
267 HEART RATE ABNORMAL 7 0.0013
268 HYPERLIPIDAEMIA 15 0.0013
269 LIMB INJURY 34 0.0013
270 STAPHYLOCOCCAL INFECTION 41 0.0012
271 INFLUENZA 138 0.0012
272 FACIAL PAIN 11 0.0012
273 KNEE OPERATION 12 0.0012
274 PANCREATIC DISORDER 6 0.0012
275 HYPERVOLAEMIA 6 0.0012
276 COLITIS 46 0.0012
277 DIABETIC NEUROPATHY 6 0.0012
278 COUGH 338 0.0012
279 BACK INJURY 13 0.0012
280 POST-TRAUMATIC STRESS DISORDER 8 0.0012
281 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 62 0.0012
282 COLITIS ISCHAEMIC 8 0.0012
283 DYSLIPIDAEMIA 6 0.0012
284 BACTERIAL INFECTION 22 0.0012
285 OROPHARYNGEAL PAIN 109 0.0012
286 DIARRHOEA HAEMORRHAGIC 11 0.0012
287 PRODUCT STORAGE ERROR 103 0.0012
288 ARTERIOSCLEROSIS 11 0.0012
289 CARDIAC OPERATION 10 0.0012
290 MUSCULOSKELETAL CHEST PAIN 18 0.0012
291 HAEMATOCRIT DECREASED 23 0.0012
292 POOR VENOUS ACCESS 12 0.0012
293 ASTHMA 131 0.0012
294 LUNG INFECTION 18 0.0012
295 PLATELET COUNT ABNORMAL 7 0.0012
296 LYMPHOEDEMA 8 0.0012
297 TENDERNESS 12 0.0012
298 HEART RATE IRREGULAR 26 0.0011
299 PLATELET COUNT INCREASED 15 0.0011
300 BONE DENSITY DECREASED 36 0.0011
301 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
302 MYOCARDIAL ISCHAEMIA 13 0.0011
303 PRODUCT AVAILABILITY ISSUE 26 0.0011
304 DISSEMINATED INTRAVASCULAR COAGULATION 16 0.0011
305 BLOOD LACTATE DEHYDROGENASE INCREASED 18 0.0011
306 BLOOD POTASSIUM DECREASED 34 0.0011
307 HAND FRACTURE 8 0.0011
308 SINUS TACHYCARDIA 16 0.0011
309 PHARYNGEAL SWELLING 11 0.0011
310 EPSTEIN-BARR VIRUS INFECTION 7 0.0011
311 HEREDITARY ANGIOEDEMA 12 0.0011
312 STENT PLACEMENT 9 0.0011
313 ANAL ABSCESS 6 0.0011
314 IMPAIRED QUALITY OF LIFE 16 0.0011
315 DEEP VEIN THROMBOSIS 72 0.0011
316 EMOTIONAL DISTRESS 134 0.0011
317 POST PROCEDURAL INFECTION 9 0.0011
318 INFECTION 160 0.0011
319 RHINORRHOEA 71 0.0011
320 WHITE BLOOD CELL COUNT ABNORMAL 7 0.0011
321 BLOOD IRON DECREASED 13 0.0011
322 ORAL DISORDER 8 0.0011
323 ROTATOR CUFF SYNDROME 14 0.0011
324 DRUG LEVEL BELOW THERAPEUTIC 6 0.0011
325 CYSTIC FIBROSIS 6 0.0011
326 INTRACRANIAL PRESSURE INCREASED 6 0.0011
327 LOCALISED INFECTION 26 0.0011
328 RENAL DISORDER 50 0.0011
329 MALNUTRITION 12 0.0011
330 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
331 MENTAL STATUS CHANGES 29 0.0010
332 RENAL FAILURE CHRONIC 8 0.0010
333 MOUTH SWELLING 6 0.0010
334 HAEMOPTYSIS 29 0.0010
335 METASTASES TO LYMPH NODES 7 0.0010
336 IRRITABLE BOWEL SYNDROME 22 0.0010
337 LYMPHOCYTE COUNT DECREASED 18 0.0010
338 HEPATOMEGALY 10 0.0010
339 WHITE BLOOD CELL COUNT INCREASED 39 0.0010
340 RESPIRATION ABNORMAL 7 0.0010
341 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
342 DIVERTICULITIS 28 0.0010
343 HEART RATE INCREASED 100 0.0010
344 PULMONARY THROMBOSIS 11 0.0010
345 GINGIVAL PAIN 8 0.0010
346 NASOPHARYNGITIS 185 0.0010
347 PYREXIA 346 0.0010
348 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 48 0.0010
349 COVID-19 175 0.0010
350 CHEST DISCOMFORT 102 0.0010
351 SEPSIS 111 0.0010
352 DENTAL CARIES 11 0.0010
353 BLOOD COUNT ABNORMAL 15 0.0010
354 NEURALGIA 24 0.0010
355 INGUINAL HERNIA 6 0.0010
356 BACK DISORDER 16 0.0010
357 TOOTH ABSCESS 10 0.0010
358 DECUBITUS ULCER 8 0.0010
359 BLOOD CALCIUM DECREASED 11 0.0010
360 NEUTROPHIL COUNT INCREASED 10 0.0010
361 ABNORMAL FAECES 8 0.0010
362 RESPIRATORY DISORDER 29 0.0010
363 ANKLE FRACTURE 15 0.0010
364 TONGUE DISORDER 7 0.0010
365 CYST 12 0.0010
366 OLIGURIA 6 0.0010
367 HYPOXIA 34 0.0010
368 PRODUCT DISPENSING ERROR 21 0.0010
369 EYE DISCHARGE 10 0.0010
370 LYMPHADENOPATHY 34 0.0010
371 ABNORMAL BEHAVIOUR 38 0.0010
372 TRANSFUSION 10 0.0010
373 SPINAL FRACTURE 19 0.0009
374 BLOOD URINE PRESENT 18 0.0009
375 PLATELET COUNT DECREASED 101 0.0009
376 GOUT 17 0.0009
377 ELECTROLYTE IMBALANCE 11 0.0009
378 POST PROCEDURAL HAEMORRHAGE 11 0.0009
379 RED BLOOD CELL COUNT DECREASED 27 0.0009
380 PULMONARY MASS 14 0.0009
381 INJURY 66 0.0009
382 SURGERY 55 0.0009
383 BREAST PAIN 10 0.0009
384 BODY HEIGHT DECREASED 10 0.0009
385 PROCTALGIA 6 0.0009
386 BONE DISORDER 17 0.0009
387 PERIPHERAL SWELLING 143 0.0009
388 DIZZINESS POSTURAL 9 0.0009
389 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
390 DYSURIA 34 0.0009
391 LOWER RESPIRATORY TRACT INFECTION 42 0.0009
392 ASPARTATE AMINOTRANSFERASE INCREASED 49 0.0009
393 PRODUCT DOSE OMISSION ISSUE 271 0.0009
394 ANXIETY 262 0.0009
395 TROPONIN INCREASED 7 0.0009
396 NODULE 12 0.0009
397 WRIST FRACTURE 11 0.0009
398 CONJUNCTIVITIS 17 0.0009
399 MULTIPLE FRACTURES 15 0.0009
400 DEVICE RELATED INFECTION 14 0.0009
401 THYROID DISORDER 14 0.0009
402 TOOTH FRACTURE 10 0.0009
403 ADRENAL INSUFFICIENCY 11 0.0009
404 DIARRHOEA 585 0.0009
405 HYPOALBUMINAEMIA 7 0.0009
406 FRACTURE 17 0.0009
407 BRAIN INJURY 9 0.0009
408 THERAPY INTERRUPTED 64 0.0009
409 THROMBOSIS 72 0.0009
410 GASTROINTESTINAL INFLAMMATION 7 0.0009
411 HYPERSENSITIVITY 165 0.0009
412 WRONG PRODUCT ADMINISTERED 6 0.0009
413 CHROMATURIA 20 0.0009
414 OROPHARYNGEAL DISCOMFORT 8 0.0009
415 PRODUCT LABEL ISSUE 6 0.0009
416 LEUKOCYTOSIS 16 0.0009
417 OSTEOMYELITIS 16 0.0009
418 PAIN IN JAW 25 0.0009
419 BODY TEMPERATURE INCREASED 18 0.0009
420 RENAL CYST 7 0.0009
421 RESTLESS LEGS SYNDROME 16 0.0009
422 IMMUNODEFICIENCY 13 0.0009
423 ONYCHOCLASIS 6 0.0009
424 PULMONARY OEDEMA 39 0.0009
425 MIGRAINE 83 0.0009
426 UROSEPSIS 8 0.0009
427 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
428 ORAL DISCOMFORT 12 0.0009
429 PRODUCT DISTRIBUTION ISSUE 8 0.0009
430 PRODUCT ODOUR ABNORMAL 9 0.0009
431 NECK PAIN 48 0.0009
432 TOXIC EPIDERMAL NECROLYSIS 13 0.0009
433 HYPERKALAEMIA 30 0.0009
434 CRYING 31 0.0009
435 LACERATION 8 0.0008
436 DUODENAL ULCER 6 0.0008
437 RENAL PAIN 9 0.0008
438 BLOOD SODIUM DECREASED 16 0.0008
439 DEHYDRATION 113 0.0008
440 LABORATORY TEST ABNORMAL 25 0.0008
441 CARDIAC FAILURE CONGESTIVE 68 0.0008
442 FLUID RETENTION 43 0.0008
443 MENSTRUAL DISORDER 7 0.0008
444 NEUROPATHY PERIPHERAL 80 0.0008
445 WHITE BLOOD CELL COUNT DECREASED 91 0.0008
446 CHOLECYSTITIS 10 0.0008
447 FEEDING DISORDER 17 0.0008
448 TASTE DISORDER 17 0.0008
449 ORAL CANDIDIASIS 11 0.0008
450 BASAL CELL CARCINOMA 13 0.0008
451 OEDEMA 45 0.0008
452 BURSITIS 10 0.0008
453 HYPOKALAEMIA 38 0.0008
454 WOUND INFECTION 9 0.0008
455 PERICARDIAL EFFUSION 19 0.0008
456 MAJOR DEPRESSION 6 0.0008
457 CONSTIPATION 179 0.0008
458 AUTOIMMUNE DISORDER 8 0.0008
459 VITAMIN D DECREASED 7 0.0008
460 HAEMATOCHEZIA 45 0.0008
461 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9 0.0008
462 CARDIOMEGALY 10 0.0008
463 CARDIOMYOPATHY 12 0.0008
464 LIP SWELLING 27 0.0008
465 PULMONARY EMBOLISM 77 0.0008
466 URINARY INCONTINENCE 24 0.0008
467 NERVE INJURY 9 0.0008
468 RASH MACULO-PAPULAR 18 0.0008
469 OBSTRUCTIVE AIRWAYS DISORDER 9 0.0008
470 HAEMOGLOBIN DECREASED 83 0.0008
471 HYSTERECTOMY 7 0.0008
472 INTENTIONAL DOSE OMISSION 23 0.0008
473 ILEUS 10 0.0008
474 OEDEMA PERIPHERAL 98 0.0008
475 DYSPHONIA 47 0.0008
476 RASH 348 0.0008
477 BONE LOSS 12 0.0008
478 CHILLS 93 0.0008
479 CHOLELITHIASIS 26 0.0008
480 EPISTAXIS 59 0.0008
481 SLUGGISHNESS 8 0.0008
482 PSYCHOMOTOR HYPERACTIVITY 13 0.0008
483 OXYGEN SATURATION DECREASED 44 0.0008
484 HYPOPHAGIA 20 0.0008
485 DEVICE OCCLUSION 11 0.0008
486 POST PROCEDURAL COMPLICATION 15 0.0008
487 OSTEOARTHRITIS 33 0.0008
488 ANAPHYLACTIC REACTION 43 0.0008
489 BLOOD UREA INCREASED 13 0.0008
490 CATARACT 46 0.0008
491 HIATUS HERNIA 10 0.0008
492 SEIZURE 89 0.0008
493 RESPIRATORY FAILURE 56 0.0008
494 NO ADVERSE EVENT 139 0.0008
495 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 13 0.0008
496 ABDOMINAL PAIN 178 0.0008
497 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
498 FOLLICULITIS 8 0.0008
499 RENAL IMPAIRMENT 64 0.0008
500 ATRIAL FIBRILLATION 74 0.0008
501 ORAL PAIN 17 0.0008
502 RASH PAPULAR 17 0.0008
503 NERVE COMPRESSION 7 0.0008
504 HEAD INJURY 24 0.0008
505 IRON DEFICIENCY ANAEMIA 7 0.0008
506 COMPLICATION ASSOCIATED WITH DEVICE 11 0.0008
507 FULL BLOOD COUNT ABNORMAL 8 0.0008
508 MUSCULOSKELETAL DISCOMFORT 13 0.0008
509 GASTROENTERITIS 11 0.0008
510 DECREASED APPETITE 175 0.0008
511 HEPATIC STEATOSIS 14 0.0008
512 HYPOTHYROIDISM 24 0.0008
513 BLOOD PRESSURE FLUCTUATION 18 0.0007
514 APPENDICITIS 7 0.0007
515 CONTUSION 72 0.0007
516 ANAEMIA 142 0.0007
517 FIBROMYALGIA 18 0.0007
518 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 19 0.0007
519 COLD SWEAT 13 0.0007
520 HEAD DISCOMFORT 13 0.0007
521 RASH GENERALISED 19 0.0007
522 HERPES ZOSTER 42 0.0007
523 HAIR DISORDER 6 0.0007
524 WEIGHT DECREASED 203 0.0007
525 DEAFNESS 19 0.0007
526 EYE SWELLING 27 0.0007
527 HYPERCHOLESTEROLAEMIA 7 0.0007
528 ACUTE CORONARY SYNDROME 6 0.0007
529 HAIR COLOUR CHANGES 9 0.0007
530 FOOT DEFORMITY 8 0.0007
531 DRUG DISPENSING ERROR 11 0.0007
532 HAEMORRHOIDS 14 0.0007
533 ALANINE AMINOTRANSFERASE INCREASED 44 0.0007
534 WOUND 20 0.0007
535 BACK PAIN 166 0.0007
536 HAEMODIALYSIS 6 0.0007
537 LUNG DISORDER 35 0.0007
538 COELIAC DISEASE 7 0.0007
539 NEUTROPHIL COUNT DECREASED 29 0.0007
540 SKIN PLAQUE 6 0.0007
541 STOMATITIS 43 0.0007
542 EJECTION FRACTION DECREASED 11 0.0007
543 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
544 JAUNDICE 19 0.0007
545 BRAIN FOG 11 0.0007
546 IMPAIRED WORK ABILITY 15 0.0007
547 SCAB 8 0.0007
548 HAEMATURIA 24 0.0007
549 PARANOIA 12 0.0007
550 DYSPNOEA 394 0.0007
551 BLOOD MAGNESIUM DECREASED 6 0.0007
552 EMPHYSEMA 7 0.0007
553 INFLUENZA LIKE ILLNESS 57 0.0007
554 GASTROINTESTINAL DISORDER 62 0.0007
555 PREMATURE DELIVERY 11 0.0007
556 ANOSMIA 10 0.0007
557 PLEURAL EFFUSION 42 0.0007
558 PRODUCT DOSE OMISSION 45 0.0007
559 URINE OUTPUT DECREASED 6 0.0007
560 HIP FRACTURE 22 0.0007
561 GASTRITIS 18 0.0007
562 GASTRIC ULCER 13 0.0007
563 THERAPY CESSATION 35 0.0007
564 SARS-COV-2 TEST POSITIVE 9 0.0007
565 MUSCLE SPASMS 125 0.0007
566 TEMPERATURE INTOLERANCE 7 0.0007
567 RESPIRATORY RATE INCREASED 6 0.0007
568 FATIGUE 526 0.0007
569 SKIN HAEMORRHAGE 10 0.0007
570 SKIN DISCOLOURATION 31 0.0007
571 SWOLLEN TONGUE 21 0.0007
572 PAIN 413 0.0007
573 ABDOMINAL DISTENSION 70 0.0007
574 HEPATIC FUNCTION ABNORMAL 25 0.0007
575 MOBILITY DECREASED 48 0.0007
576 SEPTIC SHOCK 29 0.0007
577 PRODUCT TASTE ABNORMAL 9 0.0007
578 ANGINA PECTORIS 19 0.0007
579 TOOTHACHE 12 0.0007
580 SWELLING 62 0.0007
581 SKIN DISORDER 22 0.0007
582 URINARY RETENTION 22 0.0007
583 AORTIC ANEURYSM 5 0.0007
584 SKIN LESION 18 0.0007
585 ABDOMINAL DISCOMFORT 110 0.0007
586 FALL 218 0.0007
587 ASTHENIA 246 0.0007
588 TYPE 2 DIABETES MELLITUS 22 0.0007
589 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
590 VOMITING 306 0.0007
591 DYSSTASIA 19 0.0007
592 PHARYNGEAL OEDEMA 10 0.0006
593 SMALL INTESTINAL OBSTRUCTION 8 0.0006
594 INFUSION RELATED REACTION 43 0.0006
595 CYTOKINE RELEASE SYNDROME 13 0.0006
596 ABASIA 16 0.0006
597 LYMPHOMA 10 0.0006
598 THROAT IRRITATION 29 0.0006
599 BIPOLAR DISORDER 7 0.0006
600 MIDDLE INSOMNIA 12 0.0006
601 AGEUSIA 16 0.0006
602 GASTRIC DISORDER 22 0.0006
603 OESOPHAGITIS 7 0.0006
604 HOT FLUSH 48 0.0006
605 POISONING 8 0.0006
606 MULTI-ORGAN FAILURE 11 0.0006
607 GASTROINTESTINAL HAEMORRHAGE 53 0.0006
608 ABDOMINAL PAIN LOWER 16 0.0006
609 CHEST PAIN 117 0.0006
610 MUSCLE ATROPHY 8 0.0006
611 BLOOD BILIRUBIN INCREASED 17 0.0006
612 ULCER 10 0.0006
613 BLOOD PRESSURE INCREASED 96 0.0006
614 HYPERSOMNIA 18 0.0006
615 OBESITY 10 0.0006
616 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
617 METASTASES TO LIVER 11 0.0006
618 LETHARGY 36 0.0006
619 HOSPITALISATION 96 0.0006
620 LOWER LIMB FRACTURE 12 0.0006
621 PNEUMONITIS 17 0.0006
622 DEPRESSION 142 0.0006
623 HYPOTENSION 125 0.0006
624 UNRESPONSIVE TO STIMULI 16 0.0006
625 MITRAL VALVE INCOMPETENCE 7 0.0006
626 MUSCLE TIGHTNESS 10 0.0006
627 ARTHRALGIA 255 0.0006
628 DYSPHAGIA 58 0.0006
629 ENCEPHALOPATHY 15 0.0006
630 EATING DISORDER 13 0.0006
631 LIVER DISORDER 27 0.0006
632 SHOCK 14 0.0006
633 MUSCLE TWITCHING 14 0.0006
634 DISCOMFORT 37 0.0006
635 PALPITATIONS 71 0.0006
636 DRUG-INDUCED LIVER INJURY 19 0.0006
637 BLADDER DISORDER 6 0.0006
638 PAIN IN EXTREMITY 178 0.0006
639 DRY MOUTH 49 0.0006
640 SKIN CANCER 13 0.0006
641 INSOMNIA 160 0.0006
642 COAGULOPATHY 10 0.0006
643 INTERSTITIAL LUNG DISEASE 29 0.0006
644 GAIT INABILITY 20 0.0006
645 HAIR TEXTURE ABNORMAL 8 0.0006
646 HYPOGLYCAEMIA 29 0.0006
647 APHASIA 18 0.0006
648 UNEVALUABLE EVENT 45 0.0006
649 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
650 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 107 0.0006
651 PALLOR 16 0.0006
652 PRODUCT PRESCRIBING ERROR 14 0.0006
653 ABDOMINAL PAIN UPPER 121 0.0006
654 BLOOD PRESSURE DECREASED 39 0.0006
655 MOOD ALTERED 16 0.0006
656 RASH ERYTHEMATOUS 28 0.0006
657 TOOTH DISORDER 13 0.0006
658 PERIPHERAL COLDNESS 8 0.0006
659 HYPOACUSIS 25 0.0006
660 MUSCULAR WEAKNESS 66 0.0006
661 AGGRESSION 29 0.0006
662 PANCREATITIS ACUTE 13 0.0006
663 PRURITUS 222 0.0006
664 DIPLOPIA 15 0.0006
665 NOCTURIA 7 0.0006
666 PANIC ATTACK 21 0.0006
667 HEADACHE 361 0.0006
668 POLLAKIURIA 24 0.0006
669 HYPOMAGNESAEMIA 8 0.0006
670 RESTLESSNESS 21 0.0006
671 DERMATITIS 12 0.0006
672 MUSCULOSKELETAL PAIN 30 0.0006
673 ARTHRITIS 45 0.0006
674 RASH PRURITIC 31 0.0006
675 ERYTHEMA 117 0.0006
676 HERNIA 11 0.0006
677 SPINAL OPERATION 7 0.0006
678 INJECTION SITE EXTRAVASATION 7 0.0006
679 TARDIVE DYSKINESIA 16 0.0006
680 BLOOD CREATININE INCREASED 37 0.0006
681 DYSKINESIA 23 0.0006
682 MOOD SWINGS 18 0.0006
683 DIABETES MELLITUS 43 0.0006
684 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
685 SKIN FISSURES 11 0.0006
686 TOOTH EXTRACTION 7 0.0006
687 NAUSEA 445 0.0006
688 INFLAMMATION 29 0.0006
689 ANGER 19 0.0006
690 PNEUMONIA ASPIRATION 14 0.0006
691 HALLUCINATION 42 0.0006
692 DISABILITY 11 0.0006
693 ANAL INCONTINENCE 5 0.0006
694 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
695 BLOOD PRESSURE ABNORMAL 11 0.0006
696 MYELODYSPLASTIC SYNDROME 8 0.0006
697 SLEEP DISORDER 39 0.0006
698 UPPER LIMB FRACTURE 11 0.0006
699 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
700 BLISTER 31 0.0006
701 ASPIRATION 6 0.0005
702 GAIT DISTURBANCE 104 0.0005
703 ACUTE MYOCARDIAL INFARCTION 16 0.0005
704 BURNING SENSATION 38 0.0005
705 HEART RATE DECREASED 19 0.0005
706 SWELLING FACE 35 0.0005
707 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
708 IMMUNE SYSTEM DISORDER 7 0.0005
709 MENTAL DISORDER 23 0.0005
710 CORONARY ARTERY DISEASE 16 0.0005
711 PULMONARY HYPERTENSION 11 0.0005
712 FEBRILE NEUTROPENIA 35 0.0005
713 MUSCULOSKELETAL DISORDER 10 0.0005
714 MEMORY IMPAIRMENT 72 0.0005
715 HYPOAESTHESIA 78 0.0005
716 DRY EYE 26 0.0005
717 METASTASES TO LUNG 6 0.0005
718 DYSPEPSIA 51 0.0005
719 FREQUENT BOWEL MOVEMENTS 14 0.0005
720 MALAISE 227 0.0005
721 THROAT TIGHTNESS 14 0.0005
722 MADAROSIS 6 0.0005
723 ORTHOSTATIC HYPOTENSION 9 0.0005
724 DELUSION 8 0.0005
725 RASH MACULAR 18 0.0005
726 JOINT SWELLING 62 0.0005
727 HEPATIC ENZYME INCREASED 35 0.0005
728 FEELING ABNORMAL 123 0.0005
729 LIVER FUNCTION TEST INCREASED 11 0.0005
730 BONE PAIN 30 0.0005
731 FLATULENCE 29 0.0005
732 PROSTATIC SPECIFIC ANTIGEN INCREASED 7 0.0005
733 PRODUCT USE COMPLAINT 8 0.0005
734 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
735 RESPIRATORY DISTRESS 14 0.0005
736 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
737 DIZZINESS 252 0.0005
738 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
739 SKIN ULCER 13 0.0005
740 ABSCESS 8 0.0005
741 TINNITUS 23 0.0005
742 CONDITION AGGRAVATED 152 0.0005
743 CARPAL TUNNEL SYNDROME 7 0.0005
744 BLOOD TEST ABNORMAL 7 0.0005
745 ECZEMA 26 0.0005
746 TACHYCARDIA 44 0.0005
747 HYPERGLYCAEMIA 18 0.0005
748 VERTIGO 30 0.0005
749 INTERNATIONAL NORMALISED RATIO INCREASED 14 0.0005
750 THERAPEUTIC RESPONSE UNEXPECTED 22 0.0005
751 OSTEONECROSIS 16 0.0005
752 PLASMA CELL MYELOMA 19 0.0005
753 BALANCE DISORDER 42 0.0005
754 DRUG LEVEL INCREASED 8 0.0005
755 HYPONATRAEMIA 27 0.0005
756 SPEECH DISORDER 25 0.0005
757 ASCITES 14 0.0005
758 BRAIN OEDEMA 6 0.0005
759 PROTEINURIA 9 0.0005
760 RENAL FAILURE ACUTE 20 0.0005
761 MYALGIA 80 0.0005
762 INTRAOCULAR PRESSURE INCREASED 6 0.0005
763 RETCHING 10 0.0005
764 PROCEDURAL PAIN 13 0.0005
765 JOINT INJURY 10 0.0005
766 GLAUCOMA 9 0.0005
767 C-REACTIVE PROTEIN INCREASED 17 0.0005
768 NIGHT SWEATS 15 0.0005
769 HEPATIC FAILURE 14 0.0005
770 HYPOAESTHESIA ORAL 7 0.0005
771 TREMOR 77 0.0005
772 HAEMATOMA 12 0.0005
773 HYPERTENSION 98 0.0005
774 NIGHTMARE 16 0.0005
775 CARDIAC DISORDER 43 0.0005
776 PSORIASIS 60 0.0005
777 JOINT STIFFNESS 12 0.0005
778 TREATMENT NONCOMPLIANCE 25 0.0005
779 PANCREATITIS 24 0.0005
780 ADVERSE REACTION 6 0.0005
781 ANGIOEDEMA 20 0.0005
782 FEMUR FRACTURE 14 0.0005
783 INTESTINAL OBSTRUCTION 17 0.0005
784 HYPERHIDROSIS 58 0.0004
785 CEREBRAL INFARCTION 11 0.0004
786 IRRITABILITY 27 0.0004
787 MALIGNANT MELANOMA 6 0.0004
788 GLOSSODYNIA 10 0.0004
789 WEIGHT INCREASED 100 0.0004
790 EYE PRURITUS 15 0.0004
791 MUSCULOSKELETAL STIFFNESS 39 0.0004
792 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 15 0.0004
793 RECTAL HAEMORRHAGE 19 0.0004
794 PELVIC PAIN 8 0.0004
795 ACUTE HEPATIC FAILURE 6 0.0004
796 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
797 FLUSHING 44 0.0004
798 HUNGER 6 0.0004
799 ROAD TRAFFIC ACCIDENT 18 0.0004
800 COORDINATION ABNORMAL 6 0.0004
801 DISORIENTATION 17 0.0004
802 DRUG RESISTANCE 11 0.0004
803 SOMNOLENCE 86 0.0004
804 SKIN EXFOLIATION 36 0.0004
805 MANIA 7 0.0004
806 CARDIAC ARREST 35 0.0004
807 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
808 ALOPECIA 83 0.0004
809 EMOTIONAL DISORDER 13 0.0004
810 LIMB DISCOMFORT 13 0.0004
811 SYNCOPE 42 0.0004
812 PARALYSIS 6 0.0004
813 PULMONARY FIBROSIS 8 0.0004
814 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
815 PERICARDITIS 7 0.0004
816 NERVOUS SYSTEM DISORDER 13 0.0004
817 PRODUCT USE ISSUE 78 0.0004
818 HYPOKINESIA 6 0.0004
819 MENTAL IMPAIRMENT 10 0.0004
820 DYSTONIA 8 0.0004
821 PANCYTOPENIA 23 0.0004
822 ILL-DEFINED DISORDER 25 0.0004
823 ACCIDENTAL OVERDOSE 15 0.0004
824 DRUG INTERACTION 65 0.0004
825 EYE PAIN 23 0.0004
826 MENORRHAGIA 8 0.0004
827 METABOLIC ACIDOSIS 13 0.0004
828 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
829 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
830 MOVEMENT DISORDER 13 0.0004
831 PRODUCT USE IN UNAPPROVED INDICATION 100 0.0004
832 CONFUSIONAL STATE 65 0.0004
833 HAEMORRHAGE 42 0.0004
834 LACTIC ACIDOSIS 13 0.0004
835 INTENTIONAL PRODUCT USE ISSUE 35 0.0004
836 EOSINOPHILIA 7 0.0004
837 DYSARTHRIA 15 0.0004
838 DERMATITIS ATOPIC 21 0.0004
839 LACRIMATION INCREASED 12 0.0004
840 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
841 DEVICE FAILURE 6 0.0004
842 CEREBRAL HAEMORRHAGE 14 0.0004
843 RHEUMATOID ARTHRITIS 44 0.0004
844 OFF LABEL USE 338 0.0004
845 TOOTH LOSS 8 0.0004
846 COGNITIVE DISORDER 18 0.0004
847 ACUTE MYELOID LEUKAEMIA 6 0.0004
848 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 21 0.0004
849 CARDIO-RESPIRATORY ARREST 16 0.0004
850 CYANOSIS 6 0.0004
851 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
852 HALLUCINATION, VISUAL 8 0.0004
853 ADVERSE DRUG REACTION 34 0.0004
854 DISEASE RECURRENCE 18 0.0004
855 PNEUMOTHORAX 6 0.0004
856 DRUG INTOLERANCE 36 0.0004
857 PHOTOPHOBIA 7 0.0004
858 GENERAL PHYSICAL HEALTH DETERIORATION 43 0.0004
859 POOR QUALITY SLEEP 8 0.0004
860 VISUAL IMPAIRMENT 46 0.0004
861 PRURITUS GENERALISED 8 0.0004
862 FEELING JITTERY 7 0.0004
863 LOSS OF CONSCIOUSNESS 47 0.0004
864 THROMBOCYTOPENIA 41 0.0004
865 CEREBROVASCULAR ACCIDENT 62 0.0004
866 IMPAIRED HEALING 12 0.0004
867 VISION BLURRED 50 0.0004
868 VENTRICULAR TACHYCARDIA 6 0.0004
869 DEATH 313 0.0004
870 PHOTOSENSITIVITY REACTION 6 0.0004
871 RESPIRATORY ARREST 10 0.0004
872 CYTOMEGALOVIRUS INFECTION 6 0.0004
873 MYOCARDIAL INFARCTION 62 0.0004
874 AGITATION 26 0.0004
875 HEPATITIS 9 0.0004
876 PARAESTHESIA 55 0.0003
877 DISEASE PROGRESSION 41 0.0003
878 PSORIATIC ARTHROPATHY 14 0.0003
879 NERVOUSNESS 18 0.0003
880 NEUROTOXICITY 6 0.0003
881 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
882 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
883 OCULAR HYPERAEMIA 16 0.0003
884 CARDIAC FAILURE 27 0.0003
885 COLITIS ULCERATIVE 15 0.0003
886 EYE DISORDER 11 0.0003
887 KNEE ARTHROPLASTY 7 0.0003
888 EXPIRED PRODUCT ADMINISTERED 11 0.0003
889 PRESYNCOPE 8 0.0003
890 FEELING HOT 20 0.0003
891 BLOOD GLUCOSE INCREASED 61 0.0003
892 EXTRAPYRAMIDAL DISORDER 8 0.0003
893 THINKING ABNORMAL 6 0.0003
894 BLOOD CHOLESTEROL INCREASED 15 0.0003
895 BRADYCARDIA 17 0.0003
896 HEPATIC CIRRHOSIS 6 0.0003
897 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
898 HYPOCALCAEMIA 6 0.0003
899 DELIRIUM 11 0.0003
900 CARDIOVASCULAR DISORDER 8 0.0003
901 EYE IRRITATION 18 0.0003
902 DYSGEUSIA 23 0.0003
903 ORAL HERPES 6 0.0003
904 ARTHROPATHY 17 0.0003
905 VISUAL ACUITY REDUCED 10 0.0003
906 PRESCRIBED UNDERDOSE 6 0.0003
907 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
908 INJECTION SITE SWELLING 23 0.0003
909 DRY SKIN 40 0.0003
910 PREGNANCY 6 0.0003
911 PAIN OF SKIN 8 0.0003
912 DEVICE BREAKAGE 12 0.0003
913 BLOOD GLUCOSE DECREASED 14 0.0003
914 EXPOSURE DURING PREGNANCY 18 0.0003
915 INCORRECT DOSE ADMINISTERED 66 0.0003
916 NEOPLASM PROGRESSION 10 0.0003
917 FEELING COLD 8 0.0003
918 INTENTIONAL DRUG MISUSE 6 0.0003
919 NEUTROPENIA 39 0.0003
920 DEMENTIA 8 0.0003
921 WITHDRAWAL SYNDROME 12 0.0003
922 DRUG DOSE OMISSION 47 0.0003
923 LEUKOPENIA 14 0.0003
924 DISTURBANCE IN ATTENTION 15 0.0003
925 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
926 DRUG EFFECT INCOMPLETE 10 0.0003
927 NEEDLE ISSUE 8 0.0003
928 ARRHYTHMIA 13 0.0003
929 ANAPHYLACTIC SHOCK 7 0.0003
930 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
931 LUNG NEOPLASM MALIGNANT 11 0.0003
932 THERAPY NON-RESPONDER 12 0.0003
933 DEPRESSED MOOD 14 0.0003
934 SKIN IRRITATION 12 0.0003
935 DRUG INEFFECTIVE 345 0.0003
936 UNDERDOSE 19 0.0003
937 ABNORMAL DREAMS 7 0.0003
938 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 18 0.0003
939 AMNESIA 16 0.0002
940 LIVER INJURY 6 0.0002
941 LIVER FUNCTION TEST ABNORMAL 7 0.0002
942 NEOPLASM MALIGNANT 16 0.0002
943 MATERNAL EXPOSURE DURING PREGNANCY 21 0.0002
944 PRODUCT QUALITY ISSUE 32 0.0002
945 MEDICATION ERROR 13 0.0002
946 ERECTILE DYSFUNCTION 6 0.0002
947 EXPOSURE VIA SKIN CONTACT 6 0.0002
948 DRUG ADMINISTRATION ERROR 7 0.0002
949 ADVERSE EVENT 21 0.0002
950 CONVULSION 13 0.0002
951 ABORTION SPONTANEOUS 9 0.0002
952 INJECTION SITE PRURITUS 15 0.0002
953 DRUG EFFECT DECREASED 12 0.0002
954 BLINDNESS 9 0.0002
955 SUICIDAL IDEATION 20 0.0002
956 INTENTIONAL PRODUCT MISUSE 19 0.0002
957 INJECTION SITE MASS 8 0.0002
958 ACNE 16 0.0002
959 MULTIPLE SCLEROSIS 10 0.0002
960 COMPLETED SUICIDE 17 0.0002
961 EXTRA DOSE ADMINISTERED 8 0.0002
962 MYELOSUPPRESSION 7 0.0002
963 MULTIPLE SCLEROSIS RELAPSE 13 0.0002
964 INJECTION SITE REACTION 13 0.0002
965 TOXICITY TO VARIOUS AGENTS 31 0.0002
966 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 37 0.0002
967 TREATMENT FAILURE 15 0.0002
968 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
969 DEVICE ISSUE 16 0.0002
970 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
971 THERAPEUTIC RESPONSE DECREASED 10 0.0002
972 DEVICE LEAKAGE 7 0.0002
973 INJECTION SITE ERYTHEMA 20 0.0002
974 INJECTION SITE PAIN 48 0.0002
975 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 7 0.0001
976 SUICIDE ATTEMPT 9 0.0001
977 SKIN BURNING SENSATION 10 0.0001
978 OVERDOSE 30 0.0001
979 PRODUCT SUBSTITUTION ISSUE 8 0.0001
980 DEVICE DISLOCATION 6 0.0001
981 INJECTION SITE BRUISING 11 0.0001
982 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
983 BREAST CANCER 12 0.0001
984 DEVICE MALFUNCTION 9 0.0001
985 RENAL CANCER 6 0.0001
986 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
988 INTENTIONAL OVERDOSE 7 0.0001
989 INJECTION SITE HAEMORRHAGE 8 0.0001
990 DRUG DEPENDENCE 16 0.0001
991 PROSTATE CANCER 8 0.0001
992 DRUG WITHDRAWAL SYNDROME 6 0.0001